These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16578848)

  • 1. Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications.
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9907. PubMed ID: 16578848
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications.
    Lee TS; Saltsman KA; Ohashi H; King GL
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5141-5. PubMed ID: 2740348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C and the development of diabetic vascular complications.
    Way KJ; Katai N; King GL
    Diabet Med; 2001 Dec; 18(12):945-59. PubMed ID: 11903393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia.
    Xia P; Inoguchi T; Kern TS; Engerman RL; Oates PJ; King GL
    Diabetes; 1994 Sep; 43(9):1122-9. PubMed ID: 8070612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of early growth response gene-1 expression by insulin and glucose in vascular endothelial cells.
    Hasan RN; Phukan S; Harada S
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):988-93. PubMed ID: 12689920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of phospholipase D and protein kinase C in vascular growth induced by elevated glucose concentration.
    Yasunari K; Kohno M; Kano H; Yokokawa K; Horio T; Yoshikawa J
    Hypertension; 1996 Aug; 28(2):159-68. PubMed ID: 8707376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of oxidative stress in the pathogenesis of diabetic vascular complications.
    Sasaki S; Inoguchi T
    Diabetes Metab J; 2012 Aug; 36(4):255-61. PubMed ID: 22950054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element.
    Birch KA; Heath WF; Hermeling RN; Johnston CM; Stramm L; Dell C; Smith C; Williamson JR; Reifel-Miller A
    Diabetes; 1996 May; 45(5):642-50. PubMed ID: 8621017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation.
    Park JY; Takahara N; Gabriele A; Chou E; Naruse K; Suzuma K; Yamauchi T; Ha SW; Meier M; Rhodes CJ; King GL
    Diabetes; 2000 Jul; 49(7):1239-48. PubMed ID: 10909984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus.
    Ishii H; Koya D; King GL
    J Mol Med (Berl); 1998 Jan; 76(1):21-31. PubMed ID: 9462865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of calcium-independent phospholipase A2beta in high glucose-induced activation of RhoA, Rho kinase, and CPI-17 in cultured vascular smooth muscle cells and vascular smooth muscle hypercontractility in diabetic animals.
    Xie Z; Gong MC; Su W; Xie D; Turk J; Guo Z
    J Biol Chem; 2010 Mar; 285(12):8628-38. PubMed ID: 20086008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of protein kinase C activation and the vascular complications of diabetes.
    Das Evcimen N; King GL
    Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2.
    Xia P; Kramer RM; King GL
    J Clin Invest; 1995 Aug; 96(2):733-40. PubMed ID: 7635966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation.
    Inoguchi T; Battan R; Handler E; Sportsman JR; Heath W; King GL
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):11059-63. PubMed ID: 1438315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD(P)H oxidase.
    Inoguchi T; Tsubouchi H; Etoh T; Kakimoto M; Sonta T; Utsumi H; Sumimoto H; Yu HY; Sonoda N; Inuo M; Sato N; Sekiguchi N; Kobayashi K; Nawata H
    Curr Med Chem; 2003 Sep; 10(17):1759-64. PubMed ID: 12871120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro.
    Williams B; Gallacher B; Patel H; Orme C
    Diabetes; 1997 Sep; 46(9):1497-503. PubMed ID: 9287052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome.
    Inoguchi T; Nawata H
    Curr Drug Targets; 2005 Jun; 6(4):495-501. PubMed ID: 16026268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions.
    Suzaki Y; Yoshizumi M; Kagami S; Nishiyama A; Ozawa Y; Kyaw M; Izawa Y; Kanematsu Y; Tsuchiya K; Tamaki T
    Kidney Int; 2004 May; 65(5):1749-60. PubMed ID: 15086914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes.
    Lee EY; Chung CH; Kim JH; Joung HJ; Hong SY
    Nephrol Dial Transplant; 2006 Jun; 21(6):1496-503. PubMed ID: 16484238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of protein kinase C activation in the pathogenesis of diabetic vascular complications.
    Park JY; Ha SW; King GL
    Perit Dial Int; 1999; 19 Suppl 2():S222-7. PubMed ID: 10406523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.